search
Back to results

Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias

Primary Purpose

Dementia, Alzheimer Disease, Dementia, Vascular

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Remote-based Resistance Exercise Training
Sponsored by
Drexel University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dementia

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 55 years of age or older
  • Sedentary or not meeting the current physical activity guidelines of at least 150 minutes of moderate-to-vigorous physical activity per week
  • Live with or have a primary in-home caregiver or legal representative who can be physically present during the remote-based exercise sessions
  • Have access to a computer, tablet, or smartphone with internet and webcam access for the HIPAA compliant virtual Zoom meetings.

Exclusion Criteria:

  • Younger than 55 years of age
  • Accustomed to resistance exercise training during the previous year
  • Live with known or suggestive uncontrolled cardiovascular, metabolic, and/or renal disease
  • Live with musculoskeletal injury that precludes their ability to perform remote-based, resistance exercise training

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Remote-based Resistance Exercise Training

    Arm Description

    All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.

    Outcomes

    Primary Outcome Measures

    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding

    Secondary Outcome Measures

    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Quality of Life as measured by the Short-Form (36) Health Survey
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
    Quality of Life as measured by the Short-Form (36) Health Survey
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
    Quality of Life as measured by the Short-Form (36) Health Survey
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life

    Full Information

    First Posted
    May 21, 2021
    Last Updated
    August 9, 2021
    Sponsor
    Drexel University
    Collaborators
    Mercy Health
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05004558
    Brief Title
    Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
    Official Title
    Effects of a 24-week Remote-based Resistance Training Program on Parameters of the Metabolic Syndrome, Cognitive Function, and Quality of Life in Older Adults Living With Mild Cognitive Impairment and Alzheimer's Disease and/or a Related Dementia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 1, 2021 (Anticipated)
    Primary Completion Date
    March 2022 (Anticipated)
    Study Completion Date
    June 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Drexel University
    Collaborators
    Mercy Health

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The investigators aim to study the effects of a 24-week remote-based resistance exercise training program on cardiovascular disease risk factors, cognitive function, and quality of life in older adults living with mild cognitive impairment or Alzheimer's Disease and/or a related dementia. Data for this study will be collected at the beginning, middle, and end of the resistance training program. Participants of this study will receive a baseline health-fitness assessment at the beginning of the study. Measurements of resting blood pressure, fasting blood glucose and lipids, waist and hip circumferences, height and weight, cognitive function and quality of life will be collected at the health-fitness assessment. Participants will then receive supervised remote-based resistance exercise training with Therabands, 3 days per week for 12 weeks before receiving a second 12-week health-fitness assessment in the middle of the intervention. Participants will then receive 12 additional weeks of supervised remote-based resistance exercise training with Therabands, 3 days per week for 12 weeks before receiving a third 24-week health fitness assessment at the end of the study.
    Detailed Description
    The investigators aim to study the effects of a 24-week remote-based resistance exercise training program on cardiovascular disease risk factors, cognitive function, and quality of life in older adults living with mild cognitive impairment or Alzheimer's Disease and/or a related dementia. Data for this study will be collected at the beginning, middle, and end of the resistance training program. Measurements of resting blood pressure will be collected with an automated blood pressure monitor. Fasting blood glucose and lipids will be retrieved from the electronic medical record or from a finger stick. Waist and hip circumferences will be collected with a tape measure. Height and weight will be collected with a physician scale. Cognitive function and quality of life will be collected from interviews using the Montreal Cognitive Assessment and Short-Form (36) Health Survey. All data collected from this study will be de-identified using the "Safe-Harbor" method, which minimizes exposure of personal health information by providing each participant with a unique participant-ID and only providing access to those who are listed and approved for access privileges. Data collected for this study will also be stored on an encrypted and password- protected hard drive, and data analyzed will be performed with the Statistical Package for the Social Sciences using analyses of covariance. When participants are enrolled in the study, he/she will be grouped on the basis of their cognitive function status from the Montreal Cognitive Assessment. All participants will then receive supervised remote-based resistance exercise training with Therabands, 3 days per week for 24 weeks. The risks of participating in exercise programs are minimal. Some of the possible risks of participating in resistance exercise include becoming tired and/or experiencing delayed onset muscle soreness, leg cramping, or muscle strain from performing resistance exercise. There are several benefits from engaging in resistance exercise programs. Participants of this study will receive health-fitness assessment at the beginning, middle, and end of the study, and as such, will benefit from being made aware of their cardiovascular disease risk factors, cognitive function, and quality of life. Other possible benefits from participation in the resistance exercise program may include improvements in muscular size and strength and/or activities of daily living.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dementia, Alzheimer Disease, Dementia, Vascular, Lewy Body Disease, Frontotemporal Dementia, Mild Cognitive Impairment, Aging, Hypertension, Obesity, Abdominal, Obesity, Body Weight, Blood Pressure, Blood Glucose, High, Blood Glucose, Low, Dyslipidemias, Quality of Life, Cognitive Impairment

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    36 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Remote-based Resistance Exercise Training
    Arm Type
    Experimental
    Arm Description
    All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
    Intervention Type
    Other
    Intervention Name(s)
    Remote-based Resistance Exercise Training
    Intervention Description
    All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
    Primary Outcome Measure Information:
    Title
    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    Baseline
    Title
    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    12 weeks
    Title
    Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    24 weeks
    Title
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    Baseline
    Title
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    12 weeks
    Title
    Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Description
    Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
    Time Frame
    24 weeks
    Title
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Description
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Time Frame
    Baseline
    Title
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Description
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Time Frame
    12 weeks
    Title
    Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Description
    Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
    Time Frame
    24 weeks
    Title
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Description
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Time Frame
    Baseline
    Title
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Description
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Time Frame
    12 weeks
    Title
    Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Description
    Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
    Time Frame
    24 weeks
    Title
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Description
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Time Frame
    Baseline
    Title
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Description
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Time Frame
    12 weeks
    Title
    Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Description
    Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
    Time Frame
    24 weeks
    Title
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    Baseline
    Title
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    12 weeks
    Title
    Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    24 weeks
    Title
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    Baseline
    Title
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    12 weeks
    Title
    Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Description
    Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
    Time Frame
    24 weeks
    Title
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Description
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Time Frame
    Baseline
    Title
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Description
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Time Frame
    12 weeks
    Title
    Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Description
    Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
    Time Frame
    24 weeks
    Title
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Description
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Time Frame
    Baseline
    Title
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Description
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Time Frame
    12 weeks
    Title
    High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Description
    High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
    Time Frame
    24 weeks
    Title
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Description
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Time Frame
    Baseline
    Title
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Description
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Time Frame
    12 weeks
    Title
    Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Description
    Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
    Time Frame
    24 weeks
    Title
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Description
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Time Frame
    Baseline
    Title
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Description
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Time Frame
    12 weeks
    Title
    Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Description
    Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
    Time Frame
    24 weeks
    Title
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Description
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Time Frame
    Baseline
    Title
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Description
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Time Frame
    12 weeks
    Title
    Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Description
    Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
    Time Frame
    24 weeks
    Secondary Outcome Measure Information:
    Title
    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Description
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Time Frame
    Baseline
    Title
    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Description
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Time Frame
    12 weeks
    Title
    Cognitive Function as Measured by the Montreal Cognitive Assessment
    Description
    Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
    Time Frame
    24 weeks
    Title
    Quality of Life as measured by the Short-Form (36) Health Survey
    Description
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
    Time Frame
    Baseline
    Title
    Quality of Life as measured by the Short-Form (36) Health Survey
    Description
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
    Time Frame
    12 weeks
    Title
    Quality of Life as measured by the Short-Form (36) Health Survey
    Description
    Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
    Time Frame
    24 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    55 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: 55 years of age or older Sedentary or not meeting the current physical activity guidelines of at least 150 minutes of moderate-to-vigorous physical activity per week Live with or have a primary in-home caregiver or legal representative who can be physically present during the remote-based exercise sessions Have access to a computer, tablet, or smartphone with internet and webcam access for the HIPAA compliant virtual Zoom meetings. Exclusion Criteria: Younger than 55 years of age Accustomed to resistance exercise training during the previous year Live with known or suggestive uncontrolled cardiovascular, metabolic, and/or renal disease Live with musculoskeletal injury that precludes their ability to perform remote-based, resistance exercise training

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias

    We'll reach out to this number within 24 hrs